Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 25,000 shares at $44.20 ($1.1M) on 2009-04-20, disclosed to the SEC on 2009-04-22.
Scheduled sale ($1.1M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.17 | 1,200 | $53K | 4.8% |
| 2 | $44.18 | 3,000 | $133K | 12.0% |
| 3 | $44.19 | 13,700 | $605K | 54.8% |
| 4 | $44.20 | 300 | $13K | 1.2% |
| 5 | $44.20 | 5,700 | $252K | 22.8% |
| 6 | $44.21 | 1,100 |
| $49K |
| 4.4% |
| Total | $44.19 avg | 25,000 | $1.1M | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |